<DOC>
	<DOC>NCT00843115</DOC>
	<brief_summary>To characterize the comorbidities and medications of patients treated with donepezil in a routine clinical practice and to verify the therapeutic response of these patients.</brief_summary>
	<brief_title>Observational Study Of Donepezil In Routine Clinical Practice</brief_title>
	<detailed_description>This trial was terminated prematurely on December 31, 2007 due to difficulties in enrolling patients in the study. There were no safety or efficacy concerns regarding the study in the decision to terminate the trial.</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>DSMIV criteria for the clinical diagnosis of mild to moderate Alzheimer's Disease with or without other etiologies of dementia Mini Mental Status Examination score of 1026 Contraindication as stated in the Canadian label for donepezil Subjects treated with medication for dementia within 30 days prior to baseline</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Alzheimer's Disease, naturalistic study</keyword>
</DOC>